Life sciences strategy consultant with 4+ years advising US and EU biopharma on competitive intelligence, forecasting, and commercial strategy across oncology, neurology, and rare disease. I build epidemiology-based and patient-based forecasting models and risk-adjusted NPV analyses that inform portfolio and investment decisions, and I lead indication prioritization, market entry, and commercial due diligence engagements. My […]